EU MDR: Will You Be Able to Sell Your Medical Device in Europe after May 26?
Are you 100% confident in your EU MDR transition program? With the compliance deadline now just month away, there’s no time to waste.
MedTech Intelligence is hosting a series of online workshops to help you ensure that management of your MDR transition program is on the right path. The workshops will also provide key strategies that your company can implement now, along with how to fine-tune your transition program.
The following two online programs feature presentations and panels from subject matter experts at notified bodies and medical device companies, and will be offered in February.
- EU MDR Implementation Strategies
- When: February 4–6, 2020
- Topics include economic operators, clinical evaluation, software, hazardous materials, labeling and IFU, systems and procedure packs, and drug device combination products.
- EU MDR Risk Management
- When: April 2020
- Topics include ISO 14971:2019 overview and applicability to EU MDR and other regions; design and usability requirements; post market surveillance requirements; and additional monitoring and trending requirements.
Learn more about the EU MDR Web Seminars now!
Related Articles
-
Label and packaging artwork processes play an important role in meeting compliance for EU MDR.
-
Upgrading your enterprise labeling system could play a key role in ensuring compliance.
-
Class I device manufacturers need to keep on top of new classification rules to avoid loss of market share under the close approaching EU MDR deadline.
-
From farming to teaching to firefighting, there are many principles of non-medtech professions that can be applied to EU MDR implementation.
